Home  >  News
Eppen_TIPS_May24
you can get e-magazine links on WhatsApp. Click here
Corporate + Font Resize -

Lupin achieves significant milestone with ISO 14001 & ISO 45001 certification across all its Indian manufacturing sites, R&D centre and corporate office

Our Bureau, Mumbai
Wednesday, May 15, 2024, 17:15 Hrs  [IST]

pharma major Lupin Limited (Lupin) announced that all 12 of its manufacturing sites, its R&D Centre and corporate office in India have successfully completed rigorous audits and been certified by DNV for ISO 14001 — Environment Management Systems (EMS), and ISO 45001 — Occupational Health and Safety Management System (OHSMS). This achievement marks a significant milestone in acknowledging Lupin’s commitment to safe and sustainable operations.
 
ISO 14001 is an internationally recognized standard for Environmental Management Systems. This certification demonstrates Lupin’s dedication to minimizing its environmental footprint and fostering sustainable practices across its operations. The ISO 45001 certification underscores Lupin’s unwavering commitment to ensuring the health, safety and well-being of its employees and stakeholders.
 
Commenting on this remarkable achievement, Nilesh Gupta, managing director, Lupin, said, “We are very proud of this achievement; it acknowledges our steadfast commitment to excellence in environmental stewardship and workplace safety and is a reflection of our ongoing efforts to integrate sustainable practices into our business operations and prioritize the health and safety of our people.”
 
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

 




*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
Pharma_India_Expo24
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram